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a b s t r a c t 
Spontaneous pneumothorax (SPT) and pneumomediastinum (SPM) have been reported as 
uncommon complications of coronavirus disease (COVID-19) pneumonia. The exact inci- 
dence and risk factors are still unrecognized. We report 6 nonventilated, COVID-19 pneumo- 
nia cases with SPT and SPM and their outcomes. The major risk factors for development of 
SPT and SPM in our patients were male gender, advance age, and pre-existing lung disease. 
These complications may occur in the absence of mechanical ventilation and associated 
with increasing morbidity (chest tube insertion, sepsis, hospital admission) and mortality. 
SPT and SPM should be considered as a potential predictive factor for adverse outcome and 
probable cause of unexplained deterioration of clinical condition in COVID-19 pneumonia. 
© 2021 The Authors. Published by Elsevier Inc. on behalf of University of Washington. 
This is an open access article under the CC BY-NC-ND license 















From the beginning of the coronavirus disease (COVID-19)
outbreak in December 2019 in Wuhan City, China, the novel
COVID-19 has emerged as a global healthcare crisis [1] .
COVID-19 manifests as a multisystem disease, however, the
lung represents the most common affected target organ.✩ Competing interests: The authors have no conflicts of interests to d
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myalgia [1] . The characteristic CT scan findings of COVID-19
pneumonia are mainly bilateral, lower lobe, and peripheral
distributed ground-glass opacities. Pneumothorax and pneu-
momediastinum are rare findings [2] . There are case reports of
spontaneous pneumothorax (SPT) and pneumomediastinum
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presence of pneumothorax and pneumomediastinum may
be predictive of worse prognosis [5] . Here, we reported 6
nonventilated, COVID-19 cases with SPT and SPM. 
Case I 
A 90-year-old man with history of diabetes, chronic renal
insufficiency, chronic obstructive pulmonary disease (COPD),
and intensive care unit (ICU) admission due to COVID-19, 3
weeks before current presentation, was brought to the emer-
gency department with fever, pleuritic chest pain and severe
shortness of breath in the preceding 24 hours. His labs were
significant for hyperglycemia, leukocytosis, and inflammatory
(CRP, LDH) markers. He was hypoxic, with an SpO 2 of 85% with
14 L/min oxygen via nasal cannula, tachypneic and tachy-
cardic. There was no breath sound on the left side. 
The chest CT scan showed large, left side tension hydrop-
neumothorax causing collapse of left lung with contralateral
mediastinal shift, minimal right-sided pneumothorax Fig. 1A .
In addition to tension pneumothorax, bilateral patchy ground-
glass opacities and small subpleural blebs in the lower lobes
Fig. 1B . 
During previous ICU admission, he had received
azithromycin, ceftriaxone, dexamethasone, and supple-
mentary 10 L/oxygen by mask face with maximum 90% FiO 2
without mechanical ventilation. There was no history of
trauma or central venous line insertion. 
The tension pneumothorax was treated by insertion of a
pleural tube. In spite of ICU admission and appropriate man-
agement, he deceased with clinical features of sepsis, 3 days
after diagnosis of tension pneumothorax . 
Case 2 
A 67-year-old man with productive cough, fever, shortness of
breath, and abnormal chest radiograph presented to the emer-
gency service. He had a history of major depression, COPD,
opium addiction and tobacco smoking. Diagnosis of COVID-19
pneumonia was made based on PCR. Lymphopenia, elevated
bilirubin and IL-6 level were noted on initial blood work. Chest
CT scan at that time showed: Bilateral high-density patchy
ground glass opacities and consolidations more prominent
at the bases, bullae and cystic spaces in the peripheral and
subpleural distribution Fig. 2A . He was febrile and hypoxic
(SpO 2 of 83% with 6 L/min oxygen). He was started on supple-
mentary 15 L/oxygen via nasal cannula, corticosteroid, antibi-
otics and hydroxychloroquine. His ICU course was unremark-
able and with no need mechanical ventilation. After 5 days he
was discharged from ICU and transferred to the ward. Three
days later, he experienced pleuritic chest pain after prolonged
coughing. CT scan at this time shows new right-sided pneu-
mothorax Fig. 2B . His pneumothorax was treated by insertion
of pleural tube with appropriate resolution. 
Case 3 
A 66-year-old man with hypertriglyceridemia, hypertension,
and bronchial asthma presented to the emergency depart-
ment with sudden onset pleuritic chest pain and dyspnea.
His blood work demonstrated leukocytosis, lymphopenia,hypocalcemia, elevated triglyceride and inflammatory mark-
ers (CRP, LDH). Chest radiograph finding was suggestive for
left-sided pneumothorax and complementary chest CT scan
showed large left-sided and very small right-sided pneumoth-
orax Fig. 3A . Evidence of ground-glass opacities and consolida-
tions bilaterally due to COVID-19 were seen Fig. 3B . A pleural
catheter was placed on the left side. Follow-up chest images
revealed good resolution of right-sided pneumothorax. 
About 1 month earlier, he had history of COVID-19 pneu-
monia based on nasopharyngeal swap and ICU admission.
During ICU time, he was hypoxic and received 12/L oxygen by
nasal cannula with maximum 90% FiO 2 and no need for me-
chanical ventilation. 
Case 4 
A 60-year-old man with a diagnosis of COVID-19 pneumo-
nia and ICU admission about 2 months earlier, presented to
the emergency service with 3 days new chest pain, increased
severity of dyspnea. 
He had no risk factor. At the emergency, his vital signs were
stable, with oxygen saturation of 95% in room air. There was
asymmetry of breath sounds on auscultation with decreasing
breath sounds on the left side. With clinical suspicion to pneu-
mothorax or lung collapse, he was admitted and sent for CT
scan. CT scan of chest demonstrated left-sided pneumotho-
rax and heterogeneous ground-glass opacities and linear scar-
ring compatible with absorption stage of COVID-19 pneumo-
nia Fig. 4B . Drainage pleural catheter was inserted to control
pneumothorax. There was a significant clinical improvement.
In the following chest images, absorption of the pneumotho-
rax was observed. 
During the previous ICU admission, he had received cor-
ticosteroid, antibiotics, and supplementary oxygen by mask
face. His ICU staying was smooth and transferred to the ward
after 4 days. CT scan at that time showed bilateral patchy
high-density ground-glass opacities and consolidative lesions
Fig. 4A that are typical for progressive stage of COVID-19 in the
peripheral and peribronchovascular distribution. 
Case 5 
A 30-year-old man with 1-week history of progressive leg
swelling and pain, shortness of breath and cough was referred
to CT pulmonary angiography. CT pulmonary angiography
demonstrated multiple filling defects in the segmental and
subsegmental arteries of right lower lobe, extensive bibasilar
parenchymal consolidations Fig. 5B and as an incidental find-
ing linear air streaks and bubbles in the mediastinal soft tissue
(pneumomediastinum) Fig. 5A . The patient never smoked, no
trauma or surgery and had no hematologic or thrombophilia
abnormality. Anticoagulant therapy was started and in the
follow-up images, no progression of pneumomediastinum. 
One month before this presentation, he had severe COVID-
19 pneumonia based on current epidemiologic criteria (phys-
ical findings, CT scan of chest, and blood oxygen saturation)
and 7 days hospital admission including 1 day ICU staying.
During hospitalization time, he received dexamethasone, an-
tibiotics, supplementary oxygen by mask face with maximum
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Fig. 1 – Patient 1 90-year-old man who presented with fever, severe dyspnea, and hypoxemia. (A) Axial section of CT of the 
chest shows large left side tension hydropneumothorax causing collapse of left lung and contralateral mediastinal shift 
(long arrow), minimal air (short arrow) in right pleural space. There are patchy ground-glass opacities in the right base. (B) 
Tiny subpleural blebs (long arrow) in the posterior part of upper lobes. 
Fig. 2 – Patient 2 67-year-old man with sudden onset pleuritic chest pain and history of COPD. (A) Axial section in lung 
window shows multifocal patchy ground glass opacity, reticulations. Subpleural cysts in the upper lobes (arrow). (B) 




































90% FiO 2 and no need for intubation and mechanical ventila-
tion. 
Case 6 
A 53-year-old male with no significant history presented to
the emergency department with shortness of breath, chest
pain, and cough. He was febrile and hypoxic on presentation
with SpO 2 of 88% requiring 5/L oxygen via nasal cannula. Lym-
phopenia, elevated serum troponin level, and inflammatory
(CRP, LDH) markers were noted on initial blood work. PCR for
COVID-19 was positive. CXR revealed bilateral and extensive
air-space opacity. He was admitted and started on hydroxy-
chloroquine, azithromycin, ceftriaxone, and dexamethasone.
He received oxygen by nasal cannula with maximum 90% FiO 2 
and no need to be mechanically ventilated. 
However, the patient clinically became deteriorated with
hemodynamic instability, diminished renal function and was
transferred to the ICU. About 14 days after presentation, we
noticed worsening respiratory function and significant de-
creasing breath sound on the right side. CT scan of chest
revealed: Right-sided pneumothorax and extensive bilateral
ground-glass opacities Fig. 6 . A decision was made to place apleural catheter under CT guidance. Unfortunately, on the fol-
lowing days, the patient’s clinical status continued to worsen
with hypotension and features of septic shock syndrome, then
he expired after comfort measures were taken ( Figs. 1-6 ). 
Discussion 
The clinical course of the COVID-19 is unpredictable and
varies from asymptomatic or subclinical symptoms to severe
disease [6] with development of acute respiratory distress syn-
drome and organ failure. Due to high sensitivity and rapid ac-
cess, chest CT plays an important role in diagnosis and man-
agement of COVID-19 infection [2] and has been recognized as
the most sensitive imaging modality to detect small amounts
of pneumomediastinum and pneumothorax [7] . The most
common manifestations of COVID-19 pneumonia in chest CT
scan are multifocal ground-glass opacities with or without
consolidative areas, predominantly in peripheral, lower-lobes,
and posterior anatomic distribution [8] . These imaging find-
ings mostly correlate with histopathologic manifestations of
acute lung injury caused by SARS-CoV-2. Histologic findings of
lung injury in COVID-19 are heterogeneous and have a broad
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Fig. 3 – Patient 3 66-year-old man who presented with acute onset pleuritic chest pain. (A) Axial section of CT of the chest 
reveals large left (arrow) and minimal right sided (arrow head) pneumothorax. (B) Coronal MPR reconstruction shows 
pneumothorax (arrow), extensive areas of GGOs, consolidation seen commonly bilaterally, more predominantly in the 
posterior part of mid and lower third of lung. 
Fig. 4 – Patient 4 60-year-old man with 3 days new chest pain, increased severity of dyspnea. (A) Baseline CT scan of the 
chest reveals extensive GGOs (arrows), consolidations bilaterally, more predominant in the peripheral and 
peribronchovascular distribution on April 1. (B) Left-sided pneumothorax (arrow), heterogeneous ground-glass opacities 
and linear scarring compatible with absorption stage, 50 days later. 
Fig. 5 – Patient 5 30-year-old man with 1-week history of progressive leg swelling and pain, shortness of breath and cough. 
(A) Coronal MPR reconstruction in parenchymal window shows linear air streaks and bubbles in the mediastinal soft tissue 
(pneumomediastinum). (B) Axial slice in mediastinal window demonstrates multiple filling defects in the segmental and 
subsegmental arteries right lower lobe (arrow), bilateral consolidations (short arrow) in the lower lobes. 
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Fig. 6 – Patient 6 53-year-old male with shortness of breath, 
chest pain and cough. Axial section in parenchymal 
window reveals right sided pneumothorax (arrow) with 
extensive ground-glass opacities, enlarged small vessels, 


















































spectrum ranging from diffuse alveolar damage with hyaline
membrane formation to organizing pneumonia (OP), fibrosis
[9 ,10] , and microvascular thrombosis [11] . 
Some patients may have atypical or extrapulmonary man-
ifestations as pleural effusion, mediastinal lymphadenopa-
thy, pneumomediastinum, and pneumothorax during course
of the disease. These findings may have potential prognostic
value [12 ,13] . 
Although pneumothorax appears as a frequent and poten-
tially life-treating complication in acute respiratory distress
syndrome, especially in those who had mechanical ventila-
tion support [14] , it has only been reported in 1% of COVID-19
patients [15] . 
McGuinness et al. [16] reported approximately 15% inci-
dence of barotrauma among the COVID-19 patients requiring
invasive mechanical ventilation. Yet to date, the incidence of
SPT and SPM in the patients with no history of mechanical
ventilation is unknown. 
Etiology of pneumothorax in patients with severe COVID-
19 pneumonia is not well recognized and many factors may
precipitate the occurrence, such as the barotrauma during me-
chanical ventilation [16] , complication of central line catheter
insertion [18] , and underlying pulmonary pathology (such as
pre-existing emphysema, bulla, and cyst). The cause of pneu-
momediastinum may also be related to the abrupt increase
in intrathoracic pressure associated with Valsalva maneuver
(cough, vomiting, vigorous activity, shouting or inhalation of
an illicit drugs) and subsequently rupture of the alveoli, fol-
lowed by air dissection through the bronchovascular bundles
into the mediastinum (Macklin’s effect) [19] . 
Here, we describe 6 cases that developed SPT and SPM in
the course of COVID-19 pneumonia. 
In our case reports, the patients were male above the age
of 29 years. They did not have mechanical ventilation and
received supplementary oxygen only by facemask or nasal
cannula, 3 patients had pre-existing lung disease (COPD).
Mortality rate was 30%. The diagnosis of SPT or SPM wasmade more than 1 week after the onset of symptoms (8-50
days). In the most of patients, the lung findings at the time
of pneumothorax and pneumomediastinum diagnosis were
compatible with the absorption stage of disease [17] . 
In conclusion, the SPT and SPM in our patients could be
attributable to the sudden increase in intrathoracic pressure
during forceful coughing and subsequently rupture of dam-
aged alveolar wall or small lung cysts which had developed
in the fibrotic stage of disease [20] . The risk factors in our pa-
tients were male gender, advance age and pre-existing lung
disease especially COPD. This complication might be asso-
ciated with poor outcome in the COVID-19 pneumonia [21] .
The teaching points are that possibility of pneumothorax
and pneumomediastinum is still existing in nonventilated pa-
tients and should be considered as a cause of clinical deterio-
ration in hospitalized and nonhospitalized COVID-19 patients
[22] . 
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